| |
| |
|
Medicine Information |
|
|
|
Generating Pharmaceutical Sales before Marketing Authorization
When a patient has a serious illness and there is no approved drug available, the physician may want to try one which has not been authorized for marketing by national health authorities but has shown promise in clinical trials. European Named Patient Programs, like US compassionate use programs, offer physicians access to pharmaceuticals which have not yet been licensed. However, there is one important difference: in Europe an unlicensed drug can be reimbursed. This presents drug-makers with an opportunity to generate revenues while development is still in-progress. Significant Revenues Are Possible The additional revenues can be considerable. For example, Pharmion, a US based company focusing on Oncology and Hematology reported dramatic increases in its Thalidomide sales from $1.9 million in 2Q '03 to $15.3 million in 2Q '04, primarily due to named patient sales in Europe for Multiple Myeloma. Thalidomide sales accounted for approximately 75% of Pharmion's total revenues for the first half of 2004, according to company sources, and were generated while the product awaits marketing approval for this indication. Before receiving European Marketing Approval, Shire's Argylin® for essential thrombocythaemia generated about 5% of its total sales from its European named patient program. Though thalidomide and Agrylin were licensed in the USA for some indications, pharmaceutical companies do set-up named patient programs and receive full reimbursement for drugs that are not licensed for any indication in any market. Examples include: Insmed's SomatoKine® authorized for named patient use for Primary Lateral Sclerosis, Growth Hormone Insensitivity Syndrome (GHIS) and Severe Insulin Resistance and Protherics' ViperaTAb? authorized for named patient use for adder snake bites. Other Benefits of Named Patient Programs A named patient program can speed uptake after official launch. Physicians, who have had experience before launch, via clinical trials or named patient programs, often become early adopters and references for other physicians once the drug is freely circulating. Named patient programs, like US compassionate use programs, can increase good-will toward the company because they simplify the process of gaining access for patients in critical need. Smaller companies often can not afford the administrative time and costs of shipping drugs around the world before launch. This can lead to frustration and resentment towards a company that many physicians will remember long after a drug is officially on the market. Creating a formal channel eliminates the unfortunate need of denying requests and risking ill-will later. A named patient program should be considered an important part of a pre-launch program. It increases awareness to a pharmaceutical's existence, creates excitement, generates good-will and speeds penetration of the product after launch. Frequent Communication is Necessary If one of the objectives is to generate revenues, setting up a named patient program is just the beginning. In order to achieve success, physicians need to be aware of the product and what they need to do to get it. Typical methods of informing physicians, such as sales rep visits and ads, may not be appropriate because a license is necessary to market a drug. While physicians are used to simply writing a prescription and being done with it, named patient programs require paper-work that some find tedious. Therefore the company needs to create an appropriate communication plan and work closely with the targeted medical community to keep them informed and simplify the process. Issues to Consider You have decided to make a named patient program part of your pre-marketing plan, what now? ? Administration: Do you "go it alone" or work with a company that is experienced at administering named patient programs? There are several experienced organizations that can assist your company by gaining approval, setting-up the program, doing administration and taking care of physical distribution. If your organization is well resourced and has a pipe-line of products that will require named patient programs, it might be worthwhile acquiring the expertise internally. However, if you have few appropriate products or a stream-lined organization, it is probably best to consider outsourcing. ? Communication: You've set up the program, how do you optimize it? If you do not have an experienced European marketing group, an organization that is familiar in sales and marketing of pharmaceuticals in Europe can help you to maximize participation in the named patient program. A communication plan, if properly developed and implemented can increase product awareness, but communication concerning an unlicensed product must be done appropriately. This plan should ensure that your entire target group: ? Is fully aware of the product AND the program ? Knows what needs to be done to take advantage of the program ? Has an advocate available to guide them through the process The Author, Dr Gene Emmer, is President of Med Services Europe B.V., a European-based consultancy focused on Sales, Marketing and Business Development of Pharmaceutical, Diagnostic and Medical Products. http://www.MedServicesEurope.com +31648566707
MORE RESOURCES:
Medicine - Google News |
|
|
|
RELATED ARTICLES
"Do you suffer from Osteoarthritis? Here's how to tell!" The most common type of arthritis is osteoarthritis (OA). This type of arthritis is commonly referred to as wear and tear arthritis or degenerative arthritis. Rogue Online Pharmacies: The Internet War Of 2005 Online Pharmacy owners who haven't been working within moral and governmental regulations are in for the ride of their lives. In past months, many of these so called "rogue pharmacies" have either voluntarily shut down or been closed by the powers that be. "Winning the War Against Rheumatoid Arthritis" RA is a condition that forces half of patients to become disabled from the work force within five to ten years? and reduces life expectancy by as much as 18 years. RA affects about one per cent of the world's adult population, most commonly women between the ages of 30 and 50. The Pain Factor Last year I told an acquaintance that at the age of 46, I had taken up running. The reply was, "Oh, that's awfully hard on your knees. Vioxx Side Effects : Are You Suffering? Have you ever taken the drug Vioxx or celebrex? In September 2004 the drug manufacturer Merck decided to recall the product after long term data suggested a serious potential side effect.This drug and others like it such as as 'Celebrex', 'Bextra' and 'Arcoxia' are part of a family of drugs known as "COX2 drugs" or "COX2 inhibitors"They have been developed with, ironically, patient safety in mind. 4 Reasons to Feel Safe Submitting an Electronic Medical Claim Electronic Medical ClaimFor years, both practices and patients have had to deal with submitting medical claims. Up until recently, claims were submitted manually, using HCFA 1500 forms. Chronic Head, Facial, Or Neck Pain That Won't Go Away - Could It Be TMJ? I stumbled across TMJ when I needed treat a literal pain in the neck that would not go away. It seemed that the pain in my neck came from my jaws. After Viagra, Its Now a Premature Orgasm Pill for Women Pfizer's exciting drug history traces back to the most popular Viagra drug, which treats erectile dysfunction in men. Now, they are gearing up to hit the bull's eye with a new premature orgasm pill for women. Marketing Authorisation - Medicinal Products Marketing Authorisation: Medicinal Products The case of R (on the application of Merck Sharp and Dohme Ltd) v Licensing Authority [2005], concerned the application for marketing authorisation for a generic product which was based on Product C (see below).The claimant had marketing authorisations for three medicinal products used in the treatment of osteoporosis and three generic companies sought marketing authorisation for Product C. Heart Disease: The Dangers Of Coronary Heart Attack And How To Avoid It What is a coronary heart attack?Are you at the risk of a coronary heart attack?Here are some insights to help you.. Bextra and Vioxx Withdrawal Spurs Price Increase Among Rivals The market for painkillers is huge. People don't like pain and inflammation, and last year Americans spent nearly $4 billion on just two of them - Vioxx and Bextra. Give Me Accutane or Give Me Death: The Politics of Prescriptions Any teenager will tell you that acne can drive you crazy, but is it dismal enough to drive you to kill yourself? Since its market debut in 1982, enraged parents and lawyers have implicated Accutane in the hospitalizations and suicide deaths of over 200 teenagers in the US.Accutane (isotretinoin) is one of Hoffman-LaRoche's most popular and controversial pharmaceuticals. Drug Interactions: Five Common Dangerous Interactions You Should Know About Prescription drugs can save your life. But interactions between prescription drugs and other drugs or with illnesses or conditions you have can lead to significant consequences. Mend Your Arthritis Pain Relief =====KNOW YOUR ARTHRITIS=====Arthritis is referred to as the nation?s number one crippling disease and the most common chronic disease in people over 40, arthritis affects more than 40 million Americans.And this figure is expected to rise to 60 million by 2020, according to the Center for Disease Control. Web Therapy: Enhancing Patient Communication with Web Access According to Jennifer Lyons' chart, she's just a bad slip and fall who's lucky enough to be on her way to a full recovery.But to Jennifer, who is lying in bed with a broken mandible and broken limbs, nothing could be further from the truth. Generic Medicines Generic DrugsGeneric Online Pharmacies started making a big impact on the net since the mid to late 90's. This has allowed the prescription drug buyer to save hundreds with the click of a mouse. Pediatric Emergency Contact Notifications Made Easier For the head of the trauma department at one of America's top pediatric facilities, Chicago's Children's Memorial Hospital, having to notifying parents that their children have been the victims of trauma or identify pediatric Jane Does, is an every day occurrence. But just because they look like they're handling it well, doesn't mean that it ever becomes routine. First Step To Addiction Recovery The first step to over comming any addiction is to detoxify the body of the addictive substance. Whether it's herion, crack, or meth detoxifcation of the liver is essential to addiction recovery. Death by Fluoride A wee bit of fluoride makes teeth and dentists happy, we're told. Dr. Root Canal Therapy: Frequently Asked Questions OverviewA diseased or injured nerve use to mean that you were likely to lose a tooth. This is no longer the case thanks to root canal therapy.
|
| home | site map | Dr. Thad Thomas |
| © 2006 |
